30 August 2024 false No description of principal activity Taxfiler 2024.6 15926561 business:PrivateLimitedCompanyLtd 2024-08-30 2025-08-31 15926561 2024-08-29 15926561 2024-08-30 2025-08-31 15926561 business:AuditExemptWithAccountantsReport 2024-08-30 2025-08-31 15926561 business:FilletedAccounts 2024-08-30 2025-08-31 15926561 2025-08-31 15926561 business:Director1 2024-08-30 2025-08-31 15926561 business:RegisteredOffice 2024-08-30 2025-08-31 15926561 core:WithinOneYear 2025-08-31 15926561 countries:EnglandWales 2024-08-30 2025-08-31 15926561 business:Micro-entities 2024-08-30 2025-08-31 iso4217:GBP xbrli:pure
Company Registration No. 15926561 (England and Wales)
Lukakis Pharma Limited Unaudited accounts for the period from 30 August 2024 to 31 August 2025
Lukakis Pharma Limited Annual report and unaudited accounts for the period from 30 August 2024 to 31 August 2025
CONTENTS
PAGE
Company information
3
Statement of financial position
4
- 2 -
Lukakis Pharma Limited Company Information for the period from 30 August 2024 to 31 August 2025
Director
Lucas Aquino-Petkos
Company Number
15926561 (England and Wales)
Registered Office
13 Ashford Road Stockport Cheshire SK4 5JX England
- 3 -
Lukakis Pharma Limited Statement of Financial Position as at 31 August 2025
2025
£
Current assets
9,394
Creditors: amounts falling due within one year
(2,483)
Net current assets
6,911
Total assets less current liabilities
6,911
Net assets
6,911
Capital and reserves
6,911
NOTES TO THE ACCOUNTS
1 Statutory information
Lukakis Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 15926561. The registered office is 13 Ashford Road, Stockport, Cheshire, SK4 5JX, England.
2 Average number of employees
During the period the average number of employees was 0.
For the period ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the board on 1 April 2026
Lucas Aquino-Petkos Director Company Registration No. 15926561
- 4 -